Genomic Health will utilize Philips’ automated digital pathology image creation, management and analysis system, and lntelliSite Pathology Solution.

The system features an enhanced pathology slide scanner, an image management system and case viewer, and is supported by advanced software tools to manage the scanning, storage, presentation, research analysis and sharing of information.

Genomic Health operations senior vice-president Jon Cassel said: "By utilizing Philips’ latest digital pathology solution, we are providing our pathologists with a state-of-the-art system that will provide the next level of scalability and efficiency for our overall pre-analytical process, adding new capabilities that will be increasingly important as worldwide demand for Genomic Health’s tests continues to grow."

lntelliSite obtained CE mark and Health Canada approval for in vitro diagnostic use. The system also received approval in Singapore and Middle East for in vitro diagnostic use.

The patient tissue samples are examined under pathology, helping in the diagnosis and treatment of a wide variety of diseases, including cancer.

Genomic tests enable physicians to provide personalized treatment for patients diagnosed with complex disease.

Philips digital pathology solutions general manager Russell Granzow said: "Digitization has the potential to open new opportunities for increased efficiency and a reduction in the shortcomings of a traditional analog histopathology workflow."

Several pathology institutions across the globe have implemented Philips digital pathology platform to improve the efficiency and quality of cancer diagnostics.

Some of the institutions include Singapore General Hospital , Belgium’s AZ Sint Jan, Austria’s two private pathology laboratories in Hall in Tirol and St. Pölten.

Image: Genomic Health will use Philips digital pathology tools for molecular diagnostic testing processes. Photo: courtesy of Koninklijke Philips N.V.